Original Article

The Clinical and Pathological Characteristics That Differentiate Cases With “Low Estrogen Receptor Expression” From Triple-Negative Breast Cancer

• Cem Karaali
• Mümin Emiroğlu
• Mustafa Değirmenci
• Murat Keser
• Semra Salimoğlu
• Canan Kelten Talu

PD-1 and PD-L1 Expression in Indian Women with Breast Cancer

• Kishan R. Bharadwa
• Kuheli Dasgupta
• Suma Mysore Narayana
• C. Ramachandra
• Suresh M.C. Babu
• Annapoorni Rangarajan
• Rekha V. Kumar

An In Silico Analysis Identified FZD9 as a Potential Prognostic Biomarker in Triple-Negative Breast Cancer Patients

• Daniel Rodrigues de Bastos
• Mércia Patrícia Ferreira Conceição
• Ana Paula Picaro Michelli
• Jean Michel Rocha Sampaio Leite
• Rafael André da Silva
• Ricardo Cesar Cintra
• Jeniffer Johana Duarte Sanchez
• Cesar Augusto Sam Tiago Vilanova-Costa
• Antonio Márcio Teodoro Cordeiro Silva

The Relationship of Mutation Carriage of BRCA1/2 and Family History in Triple-Negative Breast Cancer: Experience from a Diagnostic Center in Turkey

• Neslihan Duzkale
• Olcay Kandemir

Altered Expression of CYSLTR1 is Associated With Adverse Clinical Outcome in Triple Negative Breast Tumors: An In Silico Approach

• Andrés Galindo Céspedes
• Mércia Patrícia Ferreira Conceição
• Daniel Rodrigues de Bastos
• Gabriela Ávila de Grazia
• Jean Michel Rocha Sampaio Leite
• Renan Gomes do Nascimento
• Matthew Thomas Ferreira
• Rossana Mendoza Lopez

Correlation between the Expression of PD-L1 and Clinicopathological Parameters in Triple Negative Breast Cancer Patients

• Rabia Doğukan
• Ramazan Uçak
• Fatih Mert Doğukan
• Canan Tanık
• Bülent Çitgez
• Fevziye Kabukcuoğlu

Salvage Mastectomy Is not the Treatment of Choice for Aggressive Subtypes of Ipsilateral Breast Cancer Recurrence: A Single-Institution Retrospective Study

• Damiano Gentile
• Andrea Sagona
• Ruggero Spoto
• Davide Franceschini
• Stefano Vaccari
• Valeriano Vinci
• Ersilia Biondi
• Lorenzo Scardina
• Corrado Tinterri